Pterin-dependent biocatalysts and uses thereof

US11085060B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11085060-B2
Application numberUS-201515541114-A
CountryUS
Kind codeB2
Filing dateDec 31, 2015
Priority dateJan 2, 2015
Publication dateAug 10, 2021
Grant dateAug 10, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are biocatalysts and systems thereof for pterin-dependent enzymes and pathways and methods of making and using the same. Provided herein in some embodiments are biocatalysts having a pterin source and a pterin-dependent enzymatic pathway biologically coupled to the pterin source. Tetrahydrobiopterin (referred to herein as BH4 or BH 4) can be the pterin source. The BH4 can be synthesized by a tetrahydrobiopterin synthesis pathway. The tetrahydrobiopterin synthesis pathway can include a GTP cyclohydrase; a pyruvoyl tetrahydropterin synthase; a sepiapterin reductase, and/or any combination thereof. The biocatalyst can further contain a pterin-dependent enzymatic pathway. The pterin-dependent enzymatic pathway can be amino acid mono-oxygenase, phenylalanine hydroxylase, tryptophan hydroxylase, tyrosine hydroxylase, nitric oxide synthase, alkylglycerol monooxygenase, and/or any combination thereof.

First claim

Opening claim text (preview).

We claim: 1. A method of biocatalysis comprising the steps of: providing a metabolite of lignin to a biocatalyst comprising a pterin-dependent enzymatic pathway in the presence of a tetrahydrobiopterin source, wherein the pterin-dependent enzymatic pathway comprises an amino acid mono-oxygenase, and wherein the metabolite of lignin is one of: and wherein the amino acid mono-oxygenase is encoded by a nucleotide sequence comprising SEQ ID NO: 14 or SEQ ID NO: 15. 2. The method of claim 1 , wherein the biocatalyst further comprises a tetrahydrobiopterin recycling pathway, the tetrahydrobiopterin recycling pathway comprising: a pterin-4a-carbinolamine dehydratase; and a dihydropterin reductase. 3. The method of claim 1 , wherein the metabolite of lignin is: 4. The method of claim 1 , wherein the tetrahydrobiopterin source is a tetrahydrobiopterin synthesis pathway comprising: a GTP cyclohydrolase; a pyruvoyl tetrahydropterin synthase; and a sepiapterin reductase. 5. The method of claim 1 , wherein the biocatalyst further comprises an aromatic-l-amino acid decarboxylase. 6. The method of claim 1 , wherein the biocatalyst further comprises a terpene alkaloid synthase. 7. A method of biocatalysis comprising the steps of: providing a metabolite of lignin to a biocatalyst comprising a pterin-dependent enzymatic pathway in the presence of a tetrahydrobiopterin source, wherein the pterin-dependent enzymatic pathway comprises an amino acid mono-oxygenase, and wherein the metabolite of lignin is: 8. The method of claim 2 , wherein the pterin-4a-carbinolamine dehydratase is encoded by a nucleotide sequence comprising SEQ ID NO: 12; and the dihydropterin reductase is encoded by a nucleotide sequence comprising SEQ ID NO: 13. 9. The method of claim 4 , wherein the GTP cyclohydrolase is encoded by a nucleotide sequence comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, or SEQ ID NO: 4; the pyruvoyl tetrahydropterin synthase is encoded by a nucleotide sequence comprising SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8; and the sepiapterin reductase is encoded by a nucleotide sequence comprising SEQ ID NO: 9, SEQ ID NO: 10, or SEQ ID NO: 11. 10. The method of claim 5 , wherein the aromatic-l-amino acid decarboxylase is encoded by a nucleotide sequence comprising SEQ ID NO: 16. 11. The method of claim 6 , wherein the terpene alkaloid synthase is encoded by a nucleotide sequence comprising SEQ ID NO: 17.

Assignees

Inventors

Classifications

  • 4a-Hydroxytetrahydrobiopterin dehydratase (4.2.1.96) · CPC title

  • GTP cyclohydrolase I (3.5.4.16) · CPC title

  • acting on NADH or NADPH (1.6) · CPC title

  • Sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) (1.1.1.153) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11085060B2 cover?
Provided herein are biocatalysts and systems thereof for pterin-dependent enzymes and pathways and methods of making and using the same. Provided herein in some embodiments are biocatalysts having a pterin source and a pterin-dependent enzymatic pathway biologically coupled to the pterin source. Tetrahydrobiopterin (referred to herein as BH4 or BH 4) can be the pterin source. The BH4 can be syn…
Who is the assignee on this patent?
Georgia Tech Res Inst
What technology area does this patent fall under?
Primary CPC classification C12P17/182. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).